Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China [Phase 1]
Phase 1 study evaluating the ADACEL Tdap booster in healthy adults and children in China has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants [Phase 3]
Phase 3 study assessing the immunogenicity and safety of a booster dose of the DTaP-IPV-HB-PRP~T combined vaccine in healthy Turkish infants…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-Hep B-PRP~T Combined Vaccine with Infanrix Hexa in healthy Peruvian infants; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-HB-PRP-T (Sanofi Pasteur) to Infanrix Hexa when co-administered with Prevnar in Thai infants; results were …
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents [Phase 1, Phase 2]
Clinical trial update for the ADACEL booster vaccine in adolescents (Phase 1/Phase 2) with results posted in 2014, evaluating safety and imm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy [Phase 2]
Phase 2 study assessing the immunogenicity and safety of an acellular DPT vaccine administered during pregnancy has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule [Phase 3]
Phase 3 trial assessing the immunogenicity of a combined DTaP-IPV-Hep B-PRP~T vaccine versus PENTAXIM and ENGERIX B in infants at 2- to 4-mo…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
This update summarizes safety findings related to reactogenicity of ADACEL (Tdap) vaccine in children and adolescents aged 7 to 19 years.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® [Phase 2]
Phase 2 study evaluating PR5I, a pediatric combination vaccine with an enhanced Hepatitis B component, given concomitantly with Prevnar; the…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
Post-marketing safety study of Boostrix vaccine has completed and summarizes safety monitoring for diphtheria, tetanus, and pertussis indica…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals
A completed clinical trial examined the seroprevalence of anti-pertussis antibodies and disease awareness among Spanish healthcare professio…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine [Phase 3]
A Phase 3 trial comparing the DTaP-HB-PRP-T combined vaccine to Tritanrix-HepB/Hib, both given concomitantly with oral polio vaccine; result…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants [Phase 2]
Phase 2 trial comparing a DTaP-IPV-Hep B-PRP~T combined vaccine with PENTAXIM and ENGERIX B in Argentinean infants has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ [Phase 3]
Phase 3 immunogenicity study assessing antibody persistence and booster effects of the DTaP-HB-PRP~T combined vaccine (Tritanrix-HepB/Hib) d…
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants [Phase 3]
Phase 3 immunogenicity update evaluating antibody persistence and booster response of the DTaP-HB PRP-T combination vaccine in Filipino infa…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants [Phase 3]
Phase 3 trial comparing DTaP-HB-PRP~T with Tritanrix HepB/Hib, administered concomitantly with OPV in healthy infants; results have been pos…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents [Phase 4]
Phase 4 immunogenicity study evaluating Adacel and BOOSTRIX vaccines in adolescents has completed with results posted. The sponsor for this …
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ [Phase 3]
Phase 3 study evaluating a combined DTaP-IPV-HepB-PRP-T vaccine given after a primary series of DTaP-IPV-HepB-PRP-T or Infanrix Hexa; result…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B [Phase 3]
Phase 3 results for Quinvaxem, a pentavalent vaccine against diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type B,…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination [Phase 4]
Phase 4 study evaluating whether Quinvaxem can be interchanged with other pentavalent vaccines during routine childhood vaccinations; the tr…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China [Phase 4]
Phase 4 clinical trial assessing the safety of the PENTAXIM pentavalent vaccine given as a three-dose primary series at 2, 3, and 4 months o…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants [Phase 3]
A Phase 3 immunogenicity study evaluating antibody persistence and booster response of the Pentaxim vaccine in healthy Argentinean infants; …
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure [NA]
A completed Vanderbilt University study evaluated post-exposure prophylaxis for pertussis in vaccinated healthcare workers after exposure, w…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine [Phase 3]
Phase 3 trial evaluating the safety and immunogenicity of a serum-free DTaP-IPVvero combination vaccine, completed with results reported by …
-
CLINICAL_TRIALS trial_result · 2012-11-26Clinical Trial Update: Immunogenicity and Safety of Adacel Polio Vaccine [Phase 3]
Phase 3 trial results summarize the immunogenicity and safety of Adacel Polio Vaccine; the study is completed with results posted in 2012.